| # | Drug | Count |
|---|---|---|
| 0 | LEVONORGESTREL | 20 |
| 1 | IBUPROFEN | 15 |
| 2 | DICLOFENAC SODIUM | 13 |
| 3 | NAPROXEN | 13 |
| 4 | NAPROXEN SODIUM | 13 |
| 5 | DICLOFENAC | 12 |
| 6 | IBUPFROFEN | 12 |
| 7 | IBUPROFEN 200 MG | 12 |
| 8 | IBUPROFEN 200MG | 12 |
| 9 | IBUPROFEN CAPSULE | 12 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIFAROTENE | 1 | 0.0055 |
| 1 | METRELEPTIN | 1 | 0.0008 |
| 2 | ZALEPLON | 1 | 0.0006 |
| 3 | ECALLANTIDE | 1 | 0.0005 |
| 4 | IMMUNE GLOBULIN INTRAVENOUS (HUMAN) | 3 | 0.0005 |
| 5 | ALENDRONATE SODIUM AND CHOLECALCIFEROL | 1 | 0.0004 |
| 6 | CLADRIBINE | 3 | 0.0003 |
| 7 | PAMIDRONATE DISODIUM | 1 | 0.0003 |
| 8 | INFLIXIMAB-DYYB | 1 | 0.0003 |
| 9 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 1 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Leptin Analog [EPC] | 1 | 0.0008 |
| 1 | gamma-Aminobutyric Acid A Receptor Agonist [EPC] | 1 | 0.0006 |
| 2 | Plasma Kallikrein Inhibitor [EPC] | 1 | 0.0004 |
| 3 | Interleukin-17A Antagonist [EPC] | 11 | 0.0003 |
| 4 | Copper-containing Intrauterine Device [EPC] | 8 | 0.0002 |
| 5 | Human Immunoglobulin G [EPC] | 3 | 0.0001 |
| 6 | Provitamin D2 Compound [EPC] | 4 | 0.0001 |
| 7 | Thyroid Hormone Synthesis Inhibitor [EPC] | 1 | 0.0001 |
| 8 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 9 | Progestin [EPC] | 21 | 0.0001 |